Screening and mechanistic study of natural compounds that enhance T cell anti-tumor effects post-heat treatment
Following the approval of Chimeric Antigen Receptor T-cell Immunotherapy(CAR-T) in multiple countries, the Food and Drug Administration (FDA) approved tumor-infiltrating lymphocytes (TILs) and T-cell receptor-engineered T cells (TCR-T) treatments this year. The utilization of adoptive immunotherapy...
Saved in:
Published in | Frontiers in immunology Vol. 16; p. 1537398 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
27.03.2025
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!